6 / 64
4
GENERAL INFORMATION
| PROGRAMME & EXHIBITION GUIDE
A LETTER OF WELCOME FROM THE CONFERENCE CHAIRPERSONS
The 6th International Conference on innovative approaches in Head and Neck Oncology
(ICHNO) will be held from 16 to 18 March 2017 in Barcelona, Spain.
The European SocieTy for Radiotherapy and Oncology (ESTRO), the European Head and
Neck Society (EHNS) and the European Society of Medical Oncology (ESMO) have the
pleasure to welcome you at this conference.
This biennial conference will once again provide a unique platform for the dissemination
of the most relevant and cutting edge science and innovation in the field of head and
neck oncology. This conference has been shaping up to be a major international event in
promoting multidisciplinarity in head and neck oncology.
With major emphasis on head and neck, this meeting will specifically cover the main
following topics:
• New insights in the epidemiology and prevention of cancer
• Oncogenesis, HPV related cancers, immunology and vaccination
• Updated results of practice changing randomised trials
• Multidisciplinary management of cancers
• Molecular targeted therapies and molecular imaging
• Novel radiation and surgical treatments
• Towards individualised management of cancer
• Robotic and minimally invasive surgery
• Reconstructive and salvage surgery
• Elderly patients, co-morbidities and their impact on management
• New insight in systemic treatments of cancers
• Thyroid, nasopharynx cancers and rare cancers
• Quality of life, supportive care and management of treatment side effects.
The format of the meeting includes prestigious invited ‘state of the art lectures’; lectures
on the latest innovative approaches; proffered papers and poster presentations of new
data in the field of head and neck oncology. The programme is enriched by a debate
and interactive tumour board session where the audience will have the possibility to
participate and share their input via an electronic voting system. There is also a special
focus on presentations of new data from practice changing randomised trials. Ample time
will be given for discussions to allow in-depth interaction among the various disciplines
and the participants.
INTRODUCTION